GSK Latest Headlines

TD Cowen Remains a Hold on GlaxoSmithKline (GSK)

at www.tipranks.com (Thu, 18-Dec 10:45 AM)

FDA Greenlights GSK’s Exdensur, Offering Twice-Yearly Asthma Protection and 58% Reduction in Exacerbations

Market Chameleon (Wed, 17-Dec 7:56 AM)

More pharmas expected to sign drug pricing deals with Trump on Friday - report

at seekingalpha.com (Wed, 17-Dec 1:09 PM)

Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)

at www.tipranks.com (Wed, 17-Dec 9:35 AM)

UK’s $49 Billion R&D Plan Puts Quantum Tech on Investors’ Radar

at www.tipranks.com (Wed, 17-Dec 9:03 AM)

GSK wins FDA approval for Exdensur in severe eosinophilic asthma

at seekingalpha.com (Wed, 17-Dec 12:30 AM)

CDC signs off on change in newborn hepatitis b vaccine schedule

at seekingalpha.com (Tue, 16-Dec 11:03 PM)

Deutsche Bank Remains a Hold on GlaxoSmithKline (GSK)

at www.tipranks.com (Tue, 16-Dec 4:55 AM)

GSK’s New Study on Belantamab Mafodotin: A Potential Game-Changer for Multiple Myeloma Treatment

at www.tipranks.com (Sun, 14-Dec 11:37 AM)

GSK’s SPHERE Study Completes: A New Horizon for Pediatric HES Treatment

at www.tipranks.com (Sun, 14-Dec 11:32 AM)

GSK’s IPF Drug Study Terminated: Implications for Investors

at www.tipranks.com (Sun, 14-Dec 11:31 AM)

FDA Approves Blenrep, Delivering 51% Lower Risk of Death for Multiple Myeloma Patients—A New Chapter for GSK

Market Chameleon (Fri, 24-Oct 7:08 AM)

GSK Pre-Earnings History Points to a Sharp Rally

Market Chameleon (Mon, 20-Oct 11:01 AM)

GSK Expands Vaccine Track with Metro-Level Data—Spotlighting Local Opportunities in US Adult Immunization

Market Chameleon (Wed, 1-Oct 11:21 AM)

GSK Partners with MMRF: White Mountains Hike Rallies Funds and Awareness for Multiple Myeloma Cure

Market Chameleon (Wed, 1-Oct 7:13 AM)